Search
for
Sort by
Research 541–570 of 1000+
- Vitiligo and alopecia areata: apples and oranges?
- JAK Inhibitors for Treatment of Alopecia Areata
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Comorbidities in patients with alopecia areata
- Frontiers in alopecia areata pathobiology research
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Drug-induced alopecia after dupilumab therapy
- Vitamin D and skin diseases: A review
- Clinical Characteristics and Prognostic Factors in Early-Onset Alopecia Totalis and Alopecia Universalis
- The role of oclacitinib in the management of ischaemic dermatopathy in four dogs
- Association between Alopecia Areata, Psoriasis Vulgaris, Thyroid Disease, and Metabolic Syndrome
- Alopecia Areata
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Emerging Unconventional Therapies for Alopecia Areata
- Under Development JAK Inhibitors for Dermatologic Diseases
- Alopecia areata and subsequent Marie Antoinette syndrome following COVID-19 infection and vaccination: A case report
- Osteopontin: a new facilitating factor in alopecia areata pathogenesis?
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Association between metabolic syndrome and prevalent skin diseases: A systematic review and meta‐analysis of case‐control studies
- Does Complement Have a Role in the Pathogenesis of Alopecia Areata?
- Advance Understanding and New Treatment of Alopecia Areata
- The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland
- Frontal Fibrosing Alopecia – a review and a practical guide for clinicians
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Ophthalmologic Comorbidities in Alopecia Areata
- 368 The Unanticipated Costs, Deficits, and Other Unexpected Burdens in a Diagnosis of Alopecia Areata
- A Case Study on Exploring Immune Dysregulation in Alopecia Areata - Mechanisms and Treatments Outcomes